Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

March 15, 2011

January 12, 2023

Center for Drug Evaluation and Research

79efdd86-3643-466c-8fe3-82b6ad2e95ff

Related Documents

Tropical Disease Priority Review Vouchers

Guidance DocumentOctober 6, 2016Center for Drug Evaluation and Research
View Details →

Pre-Launch Activities Importation Requests (PLAIR): Guidance for Industry

Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
View Details →

CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports

Guidance DocumentMarch 5, 2014Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.